The project team developed MagnolAI, a sensor cloud with full-stack capabilities to continuously ingest, visualize, and transform a large amount of wearable sensor signals, in-clinic or at-home across the entire patient journey in connected clinical trials. Through MagnolAI, Lilly Digital Health is introducing connected devices, sensors, and measures to help manage trials – and as a result this allows for decentralized clinical trials in the modern era.

Hui Zhang, Executive Director, Digital Health Office, Eli Lilly and Company